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Introduction: Transforming Growth Factor-Beta 1 (TGF-β1) is a pleiotropic cytokine with 
potent anti-inflammatory property, which has been considered as an essential risk factor in the 
inflammatory process of Ischemic Stroke (IS), by involving in the pathophysiological progression 
of hypertension, atherosclerosis, and lipid metabolisms. -509C/T TGF-β1 gene polymorphism 
has been found to be associated with the risk of IS. The aim of this meta-analysis was to provide 
a relatively comprehensive account of the relation between -509C/T gene polymorphisms of 
TGF-β1 and susceptibility to IS.
Methods: Male Wistar rats were divided into sham (receiving phosphate buffered saline within 
dorsal hippocampus), pilocarpine (epileptic model of TLE), single injection BDNF (epileptic rats 
which received single high dose of BDBF within dorsal hippocampus), and multiple injections 
BDNF (epileptic rats which received BDNF in days 10, 11, 12, and 13 after induction of TLE) 
groups. Their electrocorticogram was recorded and amplitude, frequency, and duration of spikes 
were evaluated.
Results: Amplitude and frequency of epileptiform burst discharges were significantly decreased 
in animals treated with BDNF compared to pilocarpine group.
Conclusion: Our findings suggested that BDNF may modulate the epileptic activity in the 
animal model of TLE. In addition, it may have therapeutic effect for epilepsy. More studies are 
necessary to clarify the exact mechanisms of BDNF effects.
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1. Introduction
emporal Lobe Epilepsy (TLE), the most com-
mon form of partial epilepsy (Engel, 2001), 
is poorly controlled by current antiepileptic 
drugs (Cohen, Navarro, Duigou, & Miles, 
2003). The pathogenesis of TLE is still 
unclear. However, it has been shown that changes in the 
function of GABAergic signaling play an important role 
in the pathogenesis of TLE seizures (Cohen et al., 2003). 
γ-Aminobutyric acid (GABA), the main inhibitory neu-
rotransmitter in the adult central nervous system (CNS), at 
the early stages of brain development can depolarize target 
cells by an outflow of chloride ion, Cl−. Immature neurons 
with a large amount of intracellular Cl− could be depolar-
ized by releasing GABA  because of chloride efflux (Ben-
Ari et al., 2007). Two cation-chloride cotransporters regu-
late flow of neuronal Cl−:1) The Na-K-2Cl cotransporters 
(NKCC1) loads neurons with Cl− and depolarize them fol-
lowed by the release of GABA; 2) The K-Cl cotransporter 
(KCC2) normally extrudes Cl− and hyperpolarize neurons 
followed by the release of GABA (Ben-Ari, Gaiarsa, Tyzio, 
& Khazipov, 2007). In the adult brain, under pathophysi-
ological conditions such as epilepsy and trauma, alterations 
in the balance of NKCC1 and KCC2 activity may deter-
mine the hyperpolarizing, or depolarizing effects of GABA 
(Payne et al., 2003).
Various lines of evidence correlate epileptogenesis with 
altered functional expression of NKCC1 and KCC2 trans-
porters. It has been demonstrated that animals deficient 
in KCC2 exhibit frequent generalized seizures and die 
shortly after birth (Woo et al., 2002). Increase of NKCC1 
mRNA level in the piriform cortex of the rat amygdala-
kindling model of epilepsy has also been showed (Okabe 
et al., 2002). In addition, quantitative RT-PCR analyses of 
specimens taken from the subiculum of patients with drug-
resistant temporal lobe epilepsy revealed upregulation of 
NKCC1 mRNA and downregulation of KCC2 transporters 
(Palma et al., 2006). Likewise, in a study by Huberfeld et al. 
on biopsies from human epileptic tissue, perturbed chloride 
homeostasis and GABAergic signaling were demonstrated, 
and bumetanide at doses that selectively block NKCC1, 
suppressed interictal activity (Huberfeld et al., 2007).
To design appropriate treatment strategies for these types 
of epilepsies, KCC2 and NKCC1 transporters should be 
considered as the targets (Payne et al., 2003). Brain-derived 
neurotrophic factor (BDNF) is one of the players in the 
regulation of KCC2 expression. Aguado et al. indicated 
that BDNF acting via tyrosine kinase B receptor (TrkB) 
can increase KCC2 expression during early development 
in embryos (Aguado et al., 2003). On the other hand, in 
a study by Rivera et al., KCC2 expression in mature cen-
tral neurons was downregulated by BDNF (Rivera et al., 
2004), indicating two modes of BDNF-mediated regulation 
of KCC2 expression. 
Recently, Shulga et al. reported that BDNF increases 
KCC2 mRNA levels in axotomized central neurons. It sug-
gested that injured neurons reverse their response to this 
neurotrophin by switching the BDNF-induced downregula-
tion of KCC2 to upregulation (Shulga et al., 2008).
In our recent paper, we showed that both single high dose 
and multiple microinjections of BDNF can increase KCC2 
expression. In addition, NKCC1 expression was downregu-
lated by single high does injection of BDNF (Eftekhari et 
al., 2014). This study was aimed to evaluate the effect of 
BDNF treatment on epileptiform discharges in pilocarpine 
model of temporal lobe epilepsy. 
2. Methods & Materials
2.1. Animals
Adult male Wistar rats weighing 250–270 g were divided 
into sham, pilocarpine, single injection BDNF, and multiple 
injections BDNF groups. All experiments were housed in 
the controlled environment (7 AM-7 PM, light:dark cycle; 
22±1°C) with free access to food and water. 
All experiments were performed in accordance with the 
Declaration of Helsinki, and the experiments were ap-
proved by the Ethics Committee of Iran University of Med-
ical Sciences. 
2.2. Pilocarpine-induced Temporal Lobe Epilepsy
Pilocarpine hydrochloride (Sigma, 350 mg/kg), a musca-
rinic cholinergic agonist, was administered intraperitoneal-
ly (IP) to induce status epilepticus (SE). Animals were pre-
treated with the cholinergic antagonist scopolamine methyl 
nitrate (Sigma, 1 mg/kg, IP) 30 minutes before the pilocar-
pine injection to reduce peripheral cholinergic effects (Fer-
hat et al., 2003). The animals’ behavior was observed for 
several hours thereafter, and scored according to Racine’s 
classification (Racine, 1972). Only rats that displayed SE 
(stages 3–5) for 3-4 hours were selected, and this period 
of robust seizures was terminated by a single injection of 
diazepam (7 mg/kg, IP). Animals were hand fed after SE 
until they could eat and drink on their own. 
2.3. Stereotaxic surgery
Five days before the pilocarpine injection, animals were 
placed in a stereotaxic frame, under ketamine (87 mg/kg 
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IP) and xylazine (13 mg/kg IP) anesthesia. A guide cannula 
in the dorsal hippocampus (coordinates: 1.5 mm lateral and 
1.7 mm posterior to bregma, 3.0 mm deep from dura) was 
inserted stereotaxically according to Pellegrino Atlas (Pel-
legrino LJ 1979). For ECoG recording, 2 silver electrodes 
on the parietal cortex and reference electrode were implant-
ed on the nasal bulb. The animals in the multiple BDNF 
injection group received BDNF (Sigma, concentration:1μg/
μL, volume of injection:2.5 μL) through the cannula on 
days 10, 11, 12, and 13 after induction of status epilepticus. 
The animals in the single BDNF injection group received 
BDNF with a single high-dose of 10 μL BDNF with the 
same concentration on the 13th day after induction of SE. 
Age-matched epileptic rats received the same amount 
of BDNF solvent, phosphate buffered saline in the sham 
group. All of the injections were bilateral. Since there was 
no difference between sham and pilocarpine groups, their 
data were pooled together.
2.4. Checking electrocorticoencephalogram 
Animals were anesthetized with chlorhydrate (400 mg/
kg; Sigma-Aldrich) and silver electrodes were connected to 
the amplifier (EXT-02 F; NPI, Germany). Electrocorticoen-
cephalogram (ECoG) was recorded for 1 hour twice weekly 
for 12 weeks after pilocarpine injection (Karimzadeh et al., 
2012). Amplitude, frequency, and duration of epileptic ac-
tivities were evaluated by AxoScope software.
3. Results
The amplitude, frequency and duration of epileptiform 
burst discharges were compared among different groups. 
Both single and multiple microinjections of BDNF de-
creased amplitude and frequency of discharges compared 
to pilocarpine group (P<0.001, Figures 1-2), but this chang-
es were not permanent (Figure 3). In addition, there was 
no significant difference in duration of epileptiform burst 
discharges between BDNF-treated groups and pilocarpine 
group (Figure 4). The mean±SEM of all data were men-
tioned in the table 1.
4. Discussion
Various lines of evidence indicate that BDNF, a member 
of the neurotrophin family of growth factors (Leibrock et 
al., 1989), is associated with increased neuronal activity 
(Tanaka, Saito, & Matsuki, 1997), and has been consid-
ered as a pro-epileptogenic factor (Rivera et al., 2004). 
Furthermore, according to several reports, the development 
of epilepsy can be attenuated or postponed by intrahip-
pocampal delivery of BDNF (Koyama & Ikegaya, 2005; 
Paradiso et al., 2009). To address these contrasting effects 
of BDNF, it is essential to clarify TLE pathogenesis.
 While no definitive evidence exists to support a single 
mechanism for temporal lobe epileptogenesis, a large body 
of evidence suggests that depolarizing GABAergic sig-
Figure 1. The effect of BDNF treatment on the amplitude of 
epileptiform burst discharges induced by pilocarpine. The am-
plitude of spikes in both groups treated with BDNF was sig-
nificantly lower than pilocarpine group (***indicates P<0.001).
Figure 2. The effect of BDNF treatment on the frequency of 
epileptiform burst discharges induced by pilocarpine. The fre-
quency of spikes in both groups treated with BDNF was sig-
nificantly lower than pilocarpine group (***indicates P<0.001).
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naling accompanied by altered expression of the chloride 
co-transporters KCC2 and NKCC1 contributes to epilep-
tiform activity in animal models of epilepsies as well as 
human epileptic tissues (Cohen, Navarro, Clemenceau, 
Baulac, & Miles, 2002; Dzhala et al., 2005; Palma et al., 
2006; Huberfeld et al., 2007; Muñoz, Méndez, DeFelipe, 
& Alvarez-Leefmans, 2007; Pathak et al., 2007). In our 
previous study, we showed that there is a notable imbal-
ance between expression of 2 chloride transporters in an 
animal model of TLE (Eftekhari et al., 2014). This altera-
tion in the expression of chloride transporters together with 
a depolarizing, immature-like response of GABA is in line 
with other pathophysiological conditions such as neuronal 
trauma, axotomy, and spinal cord injury (Nabekura et al., 
Table 1. The mean±SEM of amplitude, frequency, and duration of spikes. There was significant decrease in the amplitude and 
frequency of spikes in BDNF-treated animals compared to pilocarpine groups (***indicates P<0.001).
Groups EEG Pilocarpine Single BDNF injection Multiple BDNF injection
Amplitude (mV) 0.69±0.06 0.24±.02*** 0.28±0.04***
Frequency (Spike/Min) 16.45±0.06 2.81±0.44*** 2.36±0.43***
Duration (ms) 5.35±1.17 4.75±0.32 4.33±0.57
Figure 3. Recording of ECoG in all experiments. A: Pilocarpine group (2 weeks post-SE), B: 
Treated group with single high dose injection of BDNF (2 weeks post-SE), C: Treated group 
with multiple injections of BDNF (2 weeks post-SE), D: Treated group with single high dose 
injection of BDNF (12 weeks post-SE), E: Treated group with multiple injections of BDNF (12 
weeks post-SE).
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2002; Payne, Rivera, Voipio, & Kaila, 2003; Shulga et al., 
2008; Boulenguez et al., 2010). The depolarizing GABA-A 
mediated response during development is due to chloride 
uptake mediated by NKCC1, and the hyperpolarizing re-
sponse in mature neurons is detectable when KCC2 expres-
sion increases causing a Cl− reduction (Rivera et al., 1999). 
Accumulating evidence indicate that upregulation of KCC2 
is induced by BDNF leading to the functional maturation 
of GABA-A mediated responses (Aguado et al., 2003; Car-
mona et al., 2006; Ludwig et al., 2011). Ludwig et al. dem-
onstrated that BDNF activates expression of the immedi-
ate early growth response 4 gene by induction of the TrkB/
mitogen activated protein kinase pathway, which stimulates 
KCC2b promoter activity (Ludwig et al., 2011). Further-
more, KCC2 expression is lower in the hippocampus of 
mice deficient in TrkB (Carmona et al., 2006) .On the other 
hand, in adult normal cortical neurons, BDNF downregu-
lates KCC2 expression (Rivera et al., 2004), indicating two 
modes of BDNF-mediated regulation of KCC2 expression; 
Upregulation during development and downregulation in 
mature central neurons (Shulga et al., 2008). 
Interestingly, Shulga et al. investigated the role of BDNF 
on KCC2 expression of axotomized corticospinal neurons, 
and demonstrated that injury activates a developmental-like 
mode of BDNF-mediated effects inducing a switch in the 
effect of BDNF on KCC2 expression from downregulatory 
to upregulatory (Shulga et al., 2008). Furthermore, Bou-
lenguez et al. showed that while KCC2 is downregulated af-
ter spinal cord injury in rats, intrathecal injection of BDNF 
(0.01 mg) can upregulate KCC2 expression 15 days after 
the injury (Boulenguez et al., 2010). In our recent study, 
we showed that application of either a single or multiple 
doses of BDNF, upregulated KCC2 expression (Eftekhari 
et al., 2014). In the current study, our data indicated that 
treatment with BDNF temporarily reduced the amplitude 
and frequency of epileptiform burst discharges. This effect 
might stabilize for a longer period of time if rats were in-
fused continuously with BDNF using osmotic minipumps. 
While recent studies point to NKCC1 inhibition as a prom-
ising strategy for TLE treatment (Huberfeld et al., 2007; 
Brandt, Nozadze, Heuchert, Rattka, & Löscher, 2010; Eft-
ekhari et al., 2013) , an increase in KCC2 expression can 
be considered an alternative treatment to bumetanide ap-
plication. If we want to focus on KCC2 activation as a TLE 
treatment strategy, it is essential to find out for how long 
after induction of TLE, BDNF can manage to upregulate 
KCC2, keeping its immature-state function. On the other 
hand, as applying exogenous BDNF is not practical and 
amenable for human patients, future experiments are need-
ed to modify KCC2 expression via endogenous BDNF. 
Although, Shulga et al. mentioned in their study that the 
endogenous levels of BDNF were not enough to upregu-
late KCC2 (Shulga et al., 2008), more recent studies point 
to the upregulation of endogenous BDNF by application 
of some hormones like thyroxin (Shulga et al., 2009) and 
statins like simvastatin (Han et al., 2011) in injured neurons. 
Future studies are warranted to assess any possible thera-
peutic effects of such agents on temporal lobe epilepsies via 
inducing endogenous BDNF.
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